Clinuvel is so highly manipulated that we almost think it's normal that a character can appear here questioning whether they actually have $200 Million and it is not shouted down. Because a totally different company in Wirecard had accounting issues?? Seriously you could pose this question on any other thread of any other company as it's just as relevant (ie not at all) to any other company as Clinuvel. CUV is very rare in that they are a small/tiny Biotech who just keeps growing profits WHILE running a blockbuster phase 3 trial with a drug that is already FDA and EMA approved and very safe and those are facts that don't apply to 99.9% of small/tiny Biotechs.
Does anyone think Clinuvel will not make $40 Million NPAT this year with EPS $0.8? Does anyone think blockbuster Phase 3 Vitiligo trial will not complete in the next few months (ie while growing profits)? Since the drug in the trial is already FDA approved and safe does anyone not believe Vitiligo will be added as a new indication? If approved does anyone think future Revenues and Profits will not be many multiples higher (CUV forecasts USD $490 - $570Million)? Has anyone heard of an already very profitable small/tiny Biotech worth only $350 Million (cash removed) achieving anything like this without the need to profit share with Big pharma?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)